Luis López-Lázaro (Luis Lopez-Lazaro)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Rheumatoid Arthritis

Ankylosing Spondylitis

Placebo Controlled

Top Venues

CPT: pharmacometrics & systems pharmacology

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Robin J Svensson, Qing-Xi Ooi, Lena E Friberg, Narendra Maharaj, Pramod Kumar Reddy, Luis López-Lázaro, Emma Hansson
Rituximab PK and PKPD evaluation based on a study in diffuse large B-cell lymphoma: influence of tumor size on PK and assessment of PK similarity. CPT: pharmacometrics & systems pharmacology (2022)
Vikram Muralidhar Haridas, Rahul Katta, Ajit Nalawade, Sandeep Kharkar, Vyacheslav Zhdan, Olena Garmish, Luis López-Lázaro, Sonica Sachdeva Batra, Suresh Kankanwadi
Pharmacokinetic Similarity and Comparative Pharmacodynamics, Safety, Efficacy, and Immunogenicity of DRL_RI Versus Reference Rituximab in Biologics-Naïve Patients with Moderate-to-Severe Rheumatoid Arthritis: A Double-Blind, Randomized, Three-Arm Study. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 34 (2) (2021)